Ledger.Open graph →
SEC Form D · filed March 1, 2023

Allarity Therapeutics, Inc

Offering
$1.2M
Sold
$1.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Thomas A. Jensen · Boston, MADirectorGerald G. Mclaughlin · Boston, MADirectorDavid A. Roth · Boston, MADirectorJames G. Cullem · Boston, MAExec · DirectorJoan G. Brown · Boston, MAExecSachin S. Bavishi · SAN FRANCISCO, CADirectorRyan Black · FLORENCE, SCExecPatrick A. Rentz · Los Angeles, CADirectorNicolin R. Decker · Broken Arrow, OKExec · DirectorGeoffrey L. Butler · New York, NYDirectorMichael Stocker · Vancouver, British Columbia, CanadaExec · DirectorNeil Branda · Vancouver, British Columbia, CanadaDirectorDirk Lange · Vancouver, British Columbia, CanadaDirectorBrent Hunter · Vancouver, British Columbia, CanadaExecDouglas Frankiw · Vancouver, British Columbia, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗